SCHEMBL2132012

SCHEMBL2132012

COC(=O)c1cncc(-c2cnc(NC(=O)NCC(F)(F)F)cc2-c2nc(C(F)(F)F)cs2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505437 0.91 — —
SCHEMBL3432677 0.91 CYP2A6 (0.43) —
SCHEMBL2132173 0.90 — —
SCHEMBL1505435 0.90 CYP2A6 (0.43) —
SCHEMBL10279260 0.89 — —
SCHEMBL1505468 0.87 CYP2A6 (0.41) —
SCHEMBL2135477 0.86 — —
SCHEMBL1505567 0.86 — —
SCHEMBL2132019 0.85 CYP2A6 (0.38) —
SCHEMBL31511983 0.85 CYP2A6 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101100-A1 HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF-211 ASTRAZENECA AB (SE) 2012-04-26 — — US disclosed
US-20120101100-A1 HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF-211 ASTRAZENECA AB (SE) 2012-04-26 — — US disclosed
WO-2011024004-A1 HETEROCYCLIC UREA DERIVATIVES USEFUL FOR TREATMENT OF BACTERIAL INFECTION ASTRAZENECA AB (SE) 2011-03-03 — — WO disclosed
WO-2009106885-A1 HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF-211 ASTRAZENECA AB (SE) 2009-09-03 — — WO disclosed
Send feedback